The dramatic global rise of MDR and XDR Enterobacterales in human medicine forced
clinicians to the reintroduction of colistin as last-resort drug. Meanwhile, colistin is used in …

Klebsiella pneumoniae is a common opportunistic pathogen that presents significant
challenges in the treatment of infections due to its resistance to multiple antibiotics. In recent …

Traditional antibiotics have been effective in many cases. However, the rise in multidrug-
resistant bacteria has diminished their therapeutic efficacy, signaling the dawn of an era …

The spread of polymyxin-resistant Klebsiella pneumoniae strains represents an emerging
health challenge, limiting treatment options for the patients. Thus, the development of new …

Multidrug-resistant gram-negative bacteria, such as carbapenem and colistin-resistant
Klebsiella pneumoniae (ColR-CRKP), represent a major problem for health systems …

Flavonoids are secondary metabolites that exhibit remarkable biological activities, including
antimicrobial properties against Klebsiella pneumoniae, a pathogen responsible for several …

Antimicrobial resistance (AMR) poses an imminent threat to global public health, driven in
part by the widespread use of antimicrobials in both humans and animals. Within the dairy …

Colistin is used as a last-line therapy against carbapenem-resistant Klebsiella pneumoniae
(CRKP). However, colistin resistance in Klebsiella pneumoniae is increasingly reported …

Klebsiella pneumoniae is a Gram-negative bacterium that colonizes the gastrointestinal tract
and nasopharynx with many being linked to nosocomial infections. Extended-spectrum β …

目的: 获取我院急诊重症监护室(EICU) 5 年来病原菌分布和耐药状况的流行病学资料,
为临床合理使用抗菌药物和经验治疗提供依据. 方法: 收集2016 年1 月—2020 年12 …